Company Overview of Vicept Therapeutics Incorporated
Vicept Therapeutics, Inc. is a biopharmaceutical company that develops products for dermatology markets. Its products include V-101 is a prescription topical formulation for the treatment of the erythema of rosacea; V-102, an actinic purpura solution; and V-103, a peri-procedural bruising solution. The company also engages in the development of topical agents for the treatment and prevention of various medical and cosmetic indications, including bruising of the skin. The company was founded in 2009 and is based in Malvern, Pennsylvania. As of July 22, 2011, Vicept Therapeutics, Inc. operates as a subsidiary of Allergan Inc.
101 Lindenwood Drive
Malvern, PA 19355
Founded in 2009
Key Executives for Vicept Therapeutics Incorporated
Similar Private Companies By Industry
|Adenios, Inc.||United States|
|Melanovus Oncology, Inc.||United States|
|Mesoblast, Inc.||United States|
|Kineta Holdings II, LLC||United States|
|TheraVasc, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Vicept Therapeutics Incorporated, please visit www.vicepttx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.